Insulin secretion from isolated rat islets induced by the novel hypoglycemic agent A-4166, a derivative of D-phenylalanine

Hormone and Metabolic Research

Volumn 30, Issue 1, 1998, Pages 42-49

  Tsukuda, K ^a   Sakurada, M ^a   Niki, I ^b   Oka, Y ^c   Kikuchi, M ^a  

^a INSTITUTE FOR ADULT DISEASES   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Glucagon; HIT cells; Pancreatic islets; Phenylalanine derivative; Somatostatin

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLUCOSE; NATEGLINIDE; PHENYLALANINE DERIVATIVE; TOLBUTAMIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BINDING; IN VITRO STUDY; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031933257     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978829     Document Type: Article

References (27)

1. Sato Y, Nishikawa M, Shinkai H, Sukegawa E. Possibility of ideal blood control by a new oral hypoglycemic agents, N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (AY4166), and its stimulator effect on insulin secretion in animals. Diabetes Research and Clinical Practice 1991; 12: 53-60
2. Shinkai H, Toi K, Izumi K, Seto Y, Fukuma M, Dan K, Toyoshima S. N-acylphenylalanines and related compounds. A new class of oral hypoglycemic agents. J Med Chem 1988; 31: 2092-7
3. Sato Y, Nishikawa M, Shinkai H. High performance liquid chromatographic method for quantitation of a new anti diabetic agent in plasma. J Chromatogr 1988; 11: 3425-33
4. Lacy PE, Kostianovsky M. Method for isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967; 16: 34-8
5. Ashcroft SJH, Hammonds P, Harrison DE. Insulin secretory responses of a clonal cell line of simian virus 40-transformed B-cells. Diabetologia 1986; 29: 727-33
6. Graines KL, Hamilton S, Boyd AE III. Characterization of the sulfonylurea receptor on beta cell membranes. J Biol Chem 1988; 263: 2589-92
7. Niki I, Welsh M, Berggren P, Hubbard P, Ashcroft SJH. Characterization of the solubilized glibenclamide receptor in a hamster pancreatic β-cell line. HIT T15. Biochem J 1991; 277: 619-24
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54
9. 86Rb efflux and glibenclamide binding. Pflügers Arch 1989; 415: 47-55
10. Groop LC, Barzilai N, Ratheiser N, Luzi L, Vahlin-Boll E, Melander A, De Fronzo RA. Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans. Diabetes Care 1991; 14: 724-7
11. Curry DL, Bennett LL, Grodsky GM. Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology 1968; 83: 572-84
12. Siconolfi-Baez L, Banerji MA, Lobovitz HE. Characterization and significance of sulfonylurea receptors. Diabetes Care 1990; 13 (Suppl. 3): 2-8
13. 3H]-glibenclamide. Biochem Pharmacol 1996; 53: 407-11
14. Malaisse WJ, Lebrun P. Mechanism of sulfonylurea-induced insulin release. Diabetes Care 1990; 13 (Suppl 3): 9-17
15. + fluxes and membrane potential in pancreatic B cells. Biochem Pharmac 1982; 31: 1407-15
16. Akiyoshi M, Kakei M, Nakazaki M, Tanaka H. A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic β-cells. Am J Physiol 1995; 268: E185-93
17. Basabe JC, Lopez NL, Victora JK, Wolff FW. Insulin secretion studied in the perfused rat pancreas. I. Effect of tolbutamide, leucine and arginine. Their interaction with diazoxide, and relation to glucose. Diabetes 1971; 20: 449-56
18. 2+ influx. Endocrinology 1994; 134: 1395-1400
19. + channel-independent glucose action. Endocrinology 1995; 136: 3942-8
20. Ullrich S, Wollheim CB. GTP-dependent inhibition of insulin secretion by epinephrine in permiabilized RINm5F cells. J Biol Chem 1988; 263: 8615-20
21. + channel in mouse pancreatic B cells. Nature 1991; 349: 77-9
22. Fujitani S, Ikenoue T, Akiyoshi M, Maki T, Yada T. Somatostatin and insulin secretion due to common mechanism by a new hypoglycemic agent, A-4166, in perfused rat pancreas. Metabolism 1996; 45: 184-9
23. Efendic S, Grill V, Nylen A, Ostensson CG. Difference in calcium dependency of insulin, glucagon and somatostatin secretion in response to glibenclamide in perfused rat pancreas. Diabetologia 1982; 22: 475-9
24. Pek S, Santiago C, Tai Y. L-leucine induced secretion of glucacon and insulin, and the "Off-Response" to L-leucine in vitro. I. Characterization of the dynamics of secretion. Endocrinology 1978; 103: 1208-18
25. Gylfe E. Nutrient secretagogues induce bimodal early changes in cytoplasmic calcium of insulin releasing ob/ob mouse B-cells. J Biol Chem 1988; 263: 13750-4
26. Blachier F, Mourtada A, Sener A, Malaisse WJ. Stimulus-secretion coupling of arginine-induced insulin release. Uptake of metabolized and non-metabolized cationic amino acids by pancreatic islets. Endocrinology 1989; 124: 134-41
27. Kikuchi M. Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel hypoglycemic agents, NN623 and A-4166. Diabetic Med 1996; 13 (Suppl. 6): S151-5